Company intelligence / Profile preview

PharmaSentinel

London, United Kingdompharmasentinel.com ↗

Ownership: Private
Development stage: Commercial

Overview

The company’s flagship product Medsii delivers AI-powered medicines news, safety alerts, recalls, side effect information, and clinical trial opportunities to both consumers and business clients. It has over 15,000 app downloads in 150 countries as of early 2021. The B2B SaaS product helps pharmaceutical companies accelerate discovery of medicines intelligence and regulatory/scientific updates.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Pay10 (license agreement for Medsii.com)

Beyond the preview

Go deeper on PharmaSentinel.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PharmaSentinel.

Explore the full profile